Development and validation of a personalized web-based calculator of aggressive recurrence after surgery for
Zi-Chen Yu1,2, Kai Wang1,2, Wen-Feng Lu3
1General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.
Background:
Aggressive recurrence (AR) is an important factor affecting prognosis after surgery for hepatocellular carcinoma (HCC). This study aimed to establish and evaluate a visual calculator to predict AR using by machine learning (ML) model.
Methods:
Patients diagnosed with HCC at an early stage were reviewed. The prediction ability of each model was evaluated using accuracy, sensitivity, specificity, precision, F1 score, and the area under the curve (AUC). Then, the model's prediction performance was evaluated by calibration curves, decision curve analysis (DCA), and precision-recall curves (PRC).
Results:
483 patients were ultimately included in this study. The baseline characteristics indicate that patients in the AR group exhibit poorer liver function and more advanced tumor features. Then, nine risk features were identified and incorporated into the nine development models, respectively. Among the models, the XGBoost model showed the best prediction ability (AUC 0.986, 95% CI: 0.983-0.988). Calibration curves, DCA, and PRC further demonstrated the robust performance and clinical applicability. Then, A web-based calculator was built.
Conclusion:
An explainable XGBoost model to predict AR for patients with early-stage HCC after surgery was feasible and effective, suggesting its superior potential in tailoring surgical strategies and optimizing personalized postoperative treatment plans.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
